Eisai Archives - Express Pharma

Balancing cost and value with TCO

DIA’s India Annual Meeting to host discussions on evolving regulatory landscape

Shares of Japan’s Eisai tumble after EU rejects Alzheimer’s drug

Eisai selects Medidata’s Clinical Data Studio to enhance clinical trial efficiency

Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says GlobalData

Eisai and EcoNaviSta collaborate to build a dementia ecosystem

Alzheimer’s drug Leqembi launched by Eisai, Biogen in China

Merck, Eisai to discontinue late-stage study for skin cancer

USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM Alzheimer’s treatment

Eisai files for approval of Alzheimer’s drug in Japan